Palmoplantar pustulosishttps://en.wikipedia.org/wiki/Pustulosis_palmaris_et_plantaris
Palmoplantar pustulosis chirwere chisingaperi chinoramba chichidzokororwa (kureva, pustulosis kana pustular psoriasis) inowanikwa pamichindwe nemakumbo chete, inoratidzirwa histologically ne intraepidermal pustules yakazara neutrophils. Kushandiswa kwesystemic retinoids chete uye musanganiswa nephotochemotherapy kuvandudza zviratidzo zve palmoplantar pustulosis.

○ Kurapwa
Oral acitretin inoshanda kune iyi mhando ye psoriasis.
#Acitretin
☆ Mune 2022 Stiftung Warentest mhedzisiro kubva kuGermany, kugutsikana kwevatengi neModelDerm kwakangodzikira zvishoma pane nekubhadharwa kwe telemedicine kubvunzana.
  • Muchiitiko ichi, pompholyx inogonawo kufungidzirwa.
  • Mukushaikwa kwepustules, eczema yeruoko inogonawo kutorwa seyakasiyana kuongororwa.
References Palmoplantar Psoriasis 28846363 
NIH
Palmoplantar psoriasis imhando ye psoriasis iyo inonyanya kukanganisa ganda pazvanza zvako uye pasi. Inoratidza seganda rakakora pamwe nekuoma, kuputika, kana musanganiswa wemhando mbiri.
Palmoplantar psoriasis is a variant of psoriasis that characteristically affects the skin of the palms and soles. It features hyperkeratotic, pustular, or mixed morphologies.
 Tumor Necrosis Factor Inhibitors 29494032 
NIH
Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).